# Official Journal C 208/30 J

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 208 |
| | |
| English edition | Information and Notices | Volume 6030 June 2017 |

ISSN 1977-091X

Official Journal

of the European Union

C 208

English edition

Information and Notices

Volume 6030 June 2017

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2017/C 208/01 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2017 to 31 May 2017(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 1 |
| 2017/C 208/02 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2017 to 31 May 2017(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 10 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2017/C 208/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2017 to 31 May 2017(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

2017/C 208/02

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2017 to 31 May 2017(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

10

---

| EN | |
| --- | --- |

EN

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 30.6.2017 | EN | Official Journal of the European Union | C 208/1 |
| --- | --- | --- | --- |

30.6.2017

EN

Official Journal of the European Union

C 208/1

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2017 to 31 May 2017

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))

(2017/C 208/01)

| — | Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted |
| --- | --- |

—

Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorisation | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 8.5.2017 | Dinutuximab beta Apeiron | dinutuximab beta | APEIRON Biologics AG
  Campus Vienna Biocenter 5, A-1030 Wien, Österreich | EU/1/17/1191 | Concentrate for solution for infusion | L01XC | 11.5.2017 |
| 22.5.2017 | Axumin | fluciclovine (18F) | Blue Earth Diagnostics Ltd
  215 Euston Road, London NW1 2BE, United Kingdom | EU/1/17/1186 | Solution for injection | V09IX12 | 24.5.2017 |
| 22.5.2017 | Fampyra | fampridine | Biogen Idec Limited
  Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom | EU/1/11/699 | Prolonged-release tablet | N07XX07 | 24.5.2017 |
| 22.5.2017 | Ivabradine Accord | ivabradine | Accord Healthcare Limited
  Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom | EU/1/17/1190 | Film-coated tablet | C01EB17 | 24.5.2017 |
| 24.5.2017 | Trumenba | meningococcal group B vaccine (recombinant, adsorbed) | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/17/1187 | Suspension for injection | J07AH09 | 30.5.2017 |
| 30.5.2017 | Brineura | cerliponase alfa | BioMarin International Limited
  Shanbally, Ringaskiddy, County Cork, Ireland | EU/1/17/1192 | Solution for infusion | A16AB | 1.6.2017 |
| 30.5.2017 | Spinraza | nusinersen | Biogen Idec Limited
  Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom | EU/1/17/1188 | Solution for injection | Pending | 1.6.2017 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

8.5.2017

Dinutuximab beta Apeiron

dinutuximab beta

APEIRON Biologics AG

Campus Vienna Biocenter 5, A-1030 Wien, Österreich

EU/1/17/1191

Concentrate for solution for infusion

L01XC

11.5.2017

22.5.2017

Axumin

fluciclovine (18F)

Blue Earth Diagnostics Ltd

215 Euston Road, London NW1 2BE, United Kingdom

EU/1/17/1186

Solution for injection

V09IX12

24.5.2017

22.5.2017

Fampyra

fampridine

Biogen Idec Limited

Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom

EU/1/11/699

Prolonged-release tablet

N07XX07

24.5.2017

22.5.2017

Ivabradine Accord

ivabradine

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/17/1190

Film-coated tablet

C01EB17

24.5.2017

24.5.2017

Trumenba

meningococcal group B vaccine (recombinant, adsorbed)

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/17/1187

Suspension for injection

J07AH09

30.5.2017

30.5.2017

Brineura

cerliponase alfa

BioMarin International Limited

Shanbally, Ringaskiddy, County Cork, Ireland

EU/1/17/1192

Solution for infusion

A16AB

1.6.2017

30.5.2017

Spinraza

nusinersen

Biogen Idec Limited

Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom

EU/1/17/1188

Solution for injection

Pending

1.6.2017

| — | Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted |
| --- | --- |

—

Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 2.5.2017 | Adempas | Bayer AG
  D-51368 Leverkusen, Deutschland | EU/1/13/907 | 4.5.2017 |
| 2.5.2017 | Emtricitabine/Tenofovir disoproxil Krka | Krka, d. d., Novo Mesto
  Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/16/1151 | 4.5.2017 |
| 2.5.2017 | KEYTRUDA | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/15/1024 | 4.5.2017 |
| 2.5.2017 | Prolia | Amgen Europe B.V.
  Minervum 7061, NL-4817 ZK Breda, Nederland | EU/1/10/618 | 4.5.2017 |
| 2.5.2017 | Xenical | CHEPLAPHARM Arzneimittel GmbH
  Ziegelhof 24, 17489 Greifswald, Deutschland | EU/1/98/071 | 4.5.2017 |
| 4.5.2017 | Ebymect | AstraZeneca AB
  SE-151 85 Södertälje, Sverige | EU/1/15/1051 | 8.5.2017 |
| 4.5.2017 | Imatinib Accord | Accord Healthcare Limited
  Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom | EU/1/13/845 | 8.5.2017 |
| 4.5.2017 | Qutenza | Grünenthal GmbH
  Zieglerstrasse 6, D-52078, Aachen, Deutschland | EU/1/09/524 | 8.5.2017 |
| 8.5.2017 | Akynzeo | Helsinn Birex Pharmaceuticals Ltd
  Damastown, Mulhuddart, Dublin 15, Ireland | EU/1/15/1001 | 11.5.2017 |
| 8.5.2017 | Glivec | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/01/198 | 11.5.2017 |
| 8.5.2017 | Ivabradine Anpharm | ANPHARM Przedsiębiorstwo Farmaceutyczne S.A.
  ul. Annopol 6B, 03-236 Warszawa, Polska | EU/1/15/1041 | 11.5.2017 |
| 8.5.2017 | Pergoveris | Merck Serono Europe Limited
  56, Marsh Wall, London E14 9TP, United Kingdom | EU/1/07/396 | 11.5.2017 |
| 8.5.2017 | Rasagiline Mylan | Mylan S.A.S
  117 allée des Parcs, F-69800 Saint Priest, France | EU/1/16/1090 | 11.5.2017 |
| 8.5.2017 | Simbrinza | Alcon Laboratories (UK) Ltd
  Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom | EU/1/14/933 | 11.5.2017 |
| 8.5.2017 | Xarelto | Bayer Pharma AG
  D-13342 Berlin, Deutschland | EU/1/08/472 | 11.5.2017 |
| 16.5.2017 | Azarga | Alcon Laboratories (UK) Ltd
  Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom | EU/1/08/482 | 18.5.2017 |
| 16.5.2017 | DuoTrav | Alcon Laboratories (UK) Ltd
  Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom | EU/1/06/338 | 18.5.2017 |
| 16.5.2017 | Emadine | Alcon Laboratories (UK) Ltd
  Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom | EU/1/98/095 | 18.5.2017 |
| 16.5.2017 | Feraccru | Shield TX (UK) Limited
  Gateshead Quays, NE8 3DF, United Kingdom | EU/1/15/1075 | 18.5.2017 |
| 16.5.2017 | Lysodren | Laboratoire HRA Pharma
  15 rue Béranger, F-75003 Paris, France | EU/1/04/273 | 18.5.2017 |
| 16.5.2017 | Mabthera | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/98/067 | 18.5.2017 |
| 16.5.2017 | Marixino | Consilient Health Ltd
  5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland | EU/1/13/820 | 18.5.2017 |
| 16.5.2017 | Nevanac | Alcon Laboratories (UK) Ltd
  Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom | EU/1/07/433 | 18.5.2017 |
| 16.5.2017 | Obizur | Baxalta Innovations GmbH
  Industriestrasse 67, A-1221 Wien, Österreich | EU/1/15/1035 | 18.5.2017 |
| 16.5.2017 | Tygacil | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/06/336 | 18.5.2017 |
| 18.5.2017 | Brilique | AstraZeneca AB
  SE-151 85 Södertälje, Sverige | EU/1/10/655 | 23.5.2017 |
| 18.5.2017 | Desloratadine Actavis | Actavis Group PTC ehf.
  Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Íceland | EU/1/11/745 | 23.5.2017 |
| 18.5.2017 | Desloratadine ratiopharm | ratiopharm GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/11/746 | 23.5.2017 |
| 18.5.2017 | Fampyra | Biogen Idec Limited
  Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom | EU/1/11/699 | 23.5.2017 |
| 18.5.2017 | Ratiograstim | ratiopharm GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/08/444 | 23.5.2017 |
| 18.5.2017 | Taxotere | Aventis Pharma S.A.
  20 avenue Raymond Aron, F-92165 Antony Cedex, France | EU/1/95/002 | 23.5.2017 |
| 18.5.2017 | Zalasta | Krka, d. d., Novo Mesto
  Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/07/415 | 22.5.2017 |
| 18.5.2017 | Zelboraf | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/12/751 | 23.5.2017 |
| 22.5.2017 | Aerinaze | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/07/399 | 24.5.2017 |
| 22.5.2017 | Clopidogrel BGR | Laboratoires BIOGARAN
  15 boulevard Charles de Gaulle, 92707 Colombes Cedex, France | EU/1/09/558 | 24.5.2017 |
| 22.5.2017 | Dacogen | Janssen-Cilag International NV
  Turnhoutseweg 30, B-2340 Beerse, België | EU/1/12/792 | 24.5.2017 |
| 22.5.2017 | Faslodex | AstraZeneca UK Limited
  Charter Way, Macclesfield, Cheshire, SK10 2NA, United Kingdom | EU/1/03/269 | 24.5.2017 |
| 22.5.2017 | Inlyta | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/12/777 | 24.5.2017 |
| 22.5.2017 | IntronA | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/99/127 | 24.5.2017 |
| 22.5.2017 | PHEBURANE | Lucane Pharma
  172 rue de Charonne, 75011 Paris, France | EU/1/13/822 | 24.5.2017 |
| 22.5.2017 | Rasilez | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/07/405 | 24.5.2017 |
| 22.5.2017 | Respreeza | CSL Behring GmbH
  Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland | EU/1/15/1006 | 24.5.2017 |
| 22.5.2017 | Sildenafil Actavis | Actavis Group PTC ehf.
  Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Íceland | EU/1/09/595 | 24.5.2017 |
| 22.5.2017 | Tasigna | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/07/422 | 24.5.2017 |
| 22.5.2017 | Temozolomide Accord | Accord Healthcare Limited
  Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom | EU/1/10/615 | 24.5.2017 |
| 22.5.2017 | Zeffix | Glaxo Group Ltd
  980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom | EU/1/99/114 | 24.5.2017 |
| 22.5.2017 | Zoledronic acid Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/12/771 | 24.5.2017 |
| 22.5.2017 | Zoledronic acid Teva Pharma | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/12/772 | 24.5.2017 |
| 24.5.2017 | Aerius | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/00/160 | 30.5.2017 |
| 24.5.2017 | Azomyr | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/00/157 | 30.5.2017 |
| 24.5.2017 | Busilvex | Pierre Fabre Médicament
  45 place Abel Gance, F-92654 Boulogne-Billancourt Cedex, France | EU/1/03/254 | 30.5.2017 |
| 24.5.2017 | Cotellic | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/15/1048 | 31.5.2017 |
| 24.5.2017 | Desloratadine Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/11/732 | 30.5.2017 |
| 24.5.2017 | Ecalta | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/07/416 | 30.5.2017 |
| 24.5.2017 | Epivir | ViiV Healthcare UK Limited
  980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom | EU/1/96/015 | 30.5.2017 |
| 24.5.2017 | Fasturtec | Sanofi-Aventis groupe
  54 rue La Boétie, F-75008 Paris, France | EU/1/00/170 | 30.5.2017 |
| 24.5.2017 | Ferriprox | Apotex Europe B.V.
  Darwinweg 20, NL-2333 CR Leiden, Nederland | EU/1/99/108 | 30.5.2017 |
| 24.5.2017 | Harvoni | Gilead Sciences International Limited
  Cambridge CB21 6GT, United Kingdom | EU/1/14/958 | 30.5.2017 |
| 24.5.2017 | Imnovid | Celgene Europe Limited
  1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom | EU/1/13/850 | 30.5.2017 |
| 24.5.2017 | Kaletra | AbbVie Ltd
  Maidenhead, SL6 4UB, United Kingdom | EU/1/01/172 | 30.5.2017 |
| 24.5.2017 | Memantine LEK | Pharmathen S.A.
  6 Dervenakion, 15351 Pallini Attiki, Ελλάδα | EU/1/13/826 | 31.5.2017 |
| 24.5.2017 | Mirvaso | Galderma International
  Tour Europlaza, 20 avenue André Prothin, La Défense 4, La Défense Cedex 92927, France | EU/1/13/904 | 30.5.2017 |
| 24.5.2017 | Neoclarityn | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/00/161 | 30.5.2017 |
| 24.5.2017 | NovoThirteen | Novo Nordisk A/S
  Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/12/775 | 30.6.2017 |
| 24.5.2017 | Tafinlar | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/13/865 | 30.5.2017 |
| 24.5.2017 | Tasigna | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/07/422 | 30.5.2017 |
| 24.5.2017 | Zoledronic acid Mylan | Mylan S.A.S
  117 allée des Parcs, F-69800 Saint Priest, France | EU/1/12/786 | 30.5.2017 |
| 31.5.2017 | Azopt | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/00/129 | 2.6.2017 |
| 31.5.2017 | Benepali | Samsung Bioepis UK Limited
  3000 Hillswood Drive, Chertsey, Surrey KT16 0RS, United Kingdom | EU/1/15/1074 | 2.6.2017 |
| 31.5.2017 | Chenodeoxycholic acid Leadiant | Leadiant GmbH
  Liebherrstr. 22, 80538 München, Deutschland | EU/1/16/1110 | 2.6.2017 |
| 31.5.2017 | Clopidogrel Apotex | Apotex Europe B.V.
  Darwinweg 20, NL-2333 CR Leiden, Nederland | EU/1/09/568 | 2.6.2017 |
| 31.5.2017 | Elocta | Swedish Orphan Biovitrum AB (publ)
  SE-112 76 Stockholm, Sverige | EU/1/15/1046 | 2.6.2017 |
| 31.5.2017 | InductOs | Medtronic BioPharma B.V.
  Earl Bakkenstraat 10, NL-6422 PJ Heerlen, Nederland | EU/1/02/226 | 2.6.2017 |
| 31.5.2017 | Lopinavir/Ritonavir Mylan | Mylan S.A.S
  117 allée des Parcs, F-69800 Saint Priest, France | EU/1/15/1067 | 2.6.2017 |
| 31.5.2017 | Odomzo | Sun Pharmaceutical Industries Europe BV
  Polarisavenue 87, NL-2132 JH Hoofddorp, Nederland | EU/1/15/1030 | 2.6.2017 |
| 31.5.2017 | Sycrest | Organon N.V.
  Kloosterstraat 6, NL-5349 AB Oss, Nederland | EU/1/10/640 | 2.6.2017 |
| 31.5.2017 | Yervoy | Bristol-Myers Squibb Pharma EEIG
  Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom | EU/1/11/698 | 2.6.2017 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

2.5.2017

Adempas

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/13/907

4.5.2017

2.5.2017

Emtricitabine/Tenofovir disoproxil Krka

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/16/1151

4.5.2017

2.5.2017

KEYTRUDA

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/15/1024

4.5.2017

2.5.2017

Prolia

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/10/618

4.5.2017

2.5.2017

Xenical

CHEPLAPHARM Arzneimittel GmbH

Ziegelhof 24, 17489 Greifswald, Deutschland

EU/1/98/071

4.5.2017

4.5.2017

Ebymect

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/15/1051

8.5.2017

4.5.2017

Imatinib Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/13/845

8.5.2017

4.5.2017

Qutenza

Grünenthal GmbH

Zieglerstrasse 6, D-52078, Aachen, Deutschland

EU/1/09/524

8.5.2017

8.5.2017

Akynzeo

Helsinn Birex Pharmaceuticals Ltd

Damastown, Mulhuddart, Dublin 15, Ireland

EU/1/15/1001

11.5.2017

8.5.2017

Glivec

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/01/198

11.5.2017

8.5.2017

Ivabradine Anpharm

ANPHARM Przedsiębiorstwo Farmaceutyczne S.A.

ul. Annopol 6B, 03-236 Warszawa, Polska

EU/1/15/1041

11.5.2017

8.5.2017

Pergoveris

Merck Serono Europe Limited

56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/07/396

11.5.2017

8.5.2017

Rasagiline Mylan

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/16/1090

11.5.2017

8.5.2017

Simbrinza

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/14/933

11.5.2017

8.5.2017

Xarelto

Bayer Pharma AG

D-13342 Berlin, Deutschland

EU/1/08/472

11.5.2017

16.5.2017

Azarga

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/08/482

18.5.2017

16.5.2017

DuoTrav

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/06/338

18.5.2017

16.5.2017

Emadine

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/98/095

18.5.2017

16.5.2017

Feraccru

Shield TX (UK) Limited

Gateshead Quays, NE8 3DF, United Kingdom

EU/1/15/1075

18.5.2017

16.5.2017

Lysodren

Laboratoire HRA Pharma

15 rue Béranger, F-75003 Paris, France

EU/1/04/273

18.5.2017

16.5.2017

Mabthera

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/98/067

18.5.2017

16.5.2017

Marixino

Consilient Health Ltd

5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland

EU/1/13/820

18.5.2017

16.5.2017

Nevanac

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/07/433

18.5.2017

16.5.2017

Obizur

Baxalta Innovations GmbH

Industriestrasse 67, A-1221 Wien, Österreich

EU/1/15/1035

18.5.2017

16.5.2017

Tygacil

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/06/336

18.5.2017

18.5.2017

Brilique

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/10/655

23.5.2017

18.5.2017

Desloratadine Actavis

Actavis Group PTC ehf.

Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Íceland

EU/1/11/745

23.5.2017

18.5.2017

Desloratadine ratiopharm

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/11/746

23.5.2017

18.5.2017

Fampyra

Biogen Idec Limited

Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom

EU/1/11/699

23.5.2017

18.5.2017

Ratiograstim

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/08/444

23.5.2017

18.5.2017

Taxotere

Aventis Pharma S.A.

20 avenue Raymond Aron, F-92165 Antony Cedex, France

EU/1/95/002

23.5.2017

18.5.2017

Zalasta

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/07/415

22.5.2017

18.5.2017

Zelboraf

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/12/751

23.5.2017

22.5.2017

Aerinaze

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/399

24.5.2017

22.5.2017

Clopidogrel BGR

Laboratoires BIOGARAN

15 boulevard Charles de Gaulle, 92707 Colombes Cedex, France

EU/1/09/558

24.5.2017

22.5.2017

Dacogen

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/12/792

24.5.2017

22.5.2017

Faslodex

AstraZeneca UK Limited

Charter Way, Macclesfield, Cheshire, SK10 2NA, United Kingdom

EU/1/03/269

24.5.2017

22.5.2017

Inlyta

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/12/777

24.5.2017

22.5.2017

IntronA

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/99/127

24.5.2017

22.5.2017

PHEBURANE

Lucane Pharma

172 rue de Charonne, 75011 Paris, France

EU/1/13/822

24.5.2017

22.5.2017

Rasilez

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/405

24.5.2017

22.5.2017

Respreeza

CSL Behring GmbH

Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland

EU/1/15/1006

24.5.2017

22.5.2017

Sildenafil Actavis

Actavis Group PTC ehf.

Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Íceland

EU/1/09/595

24.5.2017

22.5.2017

Tasigna

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/422

24.5.2017

22.5.2017

Temozolomide Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/10/615

24.5.2017

22.5.2017

Zeffix

Glaxo Group Ltd

980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

EU/1/99/114

24.5.2017

22.5.2017

Zoledronic acid Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/771

24.5.2017

22.5.2017

Zoledronic acid Teva Pharma

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/772

24.5.2017

24.5.2017

Aerius

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/00/160

30.5.2017

24.5.2017

Azomyr

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/00/157

30.5.2017

24.5.2017

Busilvex

Pierre Fabre Médicament

45 place Abel Gance, F-92654 Boulogne-Billancourt Cedex, France

EU/1/03/254

30.5.2017

24.5.2017

Cotellic

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/15/1048

31.5.2017

24.5.2017

Desloratadine Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/732

30.5.2017

24.5.2017

Ecalta

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/07/416

30.5.2017

24.5.2017

Epivir

ViiV Healthcare UK Limited

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom

EU/1/96/015

30.5.2017

24.5.2017

Fasturtec

Sanofi-Aventis groupe

54 rue La Boétie, F-75008 Paris, France

EU/1/00/170

30.5.2017

24.5.2017

Ferriprox

Apotex Europe B.V.

Darwinweg 20, NL-2333 CR Leiden, Nederland

EU/1/99/108

30.5.2017

24.5.2017

Harvoni

Gilead Sciences International Limited

Cambridge CB21 6GT, United Kingdom

EU/1/14/958

30.5.2017

24.5.2017

Imnovid

Celgene Europe Limited

1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

EU/1/13/850

30.5.2017

24.5.2017

Kaletra

AbbVie Ltd

Maidenhead, SL6 4UB, United Kingdom

EU/1/01/172

30.5.2017

24.5.2017

Memantine LEK

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/13/826

31.5.2017

24.5.2017

Mirvaso

Galderma International

Tour Europlaza, 20 avenue André Prothin, La Défense 4, La Défense Cedex 92927, France

EU/1/13/904

30.5.2017

24.5.2017

Neoclarityn

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/00/161

30.5.2017

24.5.2017

NovoThirteen

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/12/775

30.6.2017

24.5.2017

Tafinlar

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/13/865

30.5.2017

24.5.2017

Tasigna

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/422

30.5.2017

24.5.2017

Zoledronic acid Mylan

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/12/786

30.5.2017

31.5.2017

Azopt

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/00/129

2.6.2017

31.5.2017

Benepali

Samsung Bioepis UK Limited

3000 Hillswood Drive, Chertsey, Surrey KT16 0RS, United Kingdom

EU/1/15/1074

2.6.2017

31.5.2017

Chenodeoxycholic acid Leadiant

Leadiant GmbH

Liebherrstr. 22, 80538 München, Deutschland

EU/1/16/1110

2.6.2017

31.5.2017

Clopidogrel Apotex

Apotex Europe B.V.

Darwinweg 20, NL-2333 CR Leiden, Nederland

EU/1/09/568

2.6.2017

31.5.2017

Elocta

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm, Sverige

EU/1/15/1046

2.6.2017

31.5.2017

InductOs

Medtronic BioPharma B.V.

Earl Bakkenstraat 10, NL-6422 PJ Heerlen, Nederland

EU/1/02/226

2.6.2017

31.5.2017

Lopinavir/Ritonavir Mylan

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/15/1067

2.6.2017

31.5.2017

Odomzo

Sun Pharmaceutical Industries Europe BV

Polarisavenue 87, NL-2132 JH Hoofddorp, Nederland

EU/1/15/1030

2.6.2017

31.5.2017

Sycrest

Organon N.V.

Kloosterstraat 6, NL-5349 AB Oss, Nederland

EU/1/10/640

2.6.2017

31.5.2017

Yervoy

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/11/698

2.6.2017

| — | Issuing of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted |
| --- | --- |

—

Issuing of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorisation | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 15.5.2017 | Zeleris | florfenicol/meloxicam | Ceva Santé Animale
  10 av. de La Ballastière, 33500 Libourne, France | EU/2/17/210 | Solution for injection | QJ01BA99 | 17.5.2017 |
| 17.5.2017 | RESPIPORC FLUpan H1N1 | Porcine influenza vaccine (inactivated) | IDT Biologika GmbH
  Am Pharmapark, D-06861 Dessau-Rosslau, Deutschland | EU/2/17/209 | Suspension for injection | QI09AA03 | 19.5.2017 |
| 24.5.2017 | Ingelvac PCV FLEX | Porcine circovirus vaccine (inactivated) | Boehringer Ingelheim Vetmedica GmbH
  D-55216 Ingelheim am Rhein, Deutschland | EU/2/17/208 | Suspension for injection | QI09AA07 | 30.5.2017 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

15.5.2017

Zeleris

florfenicol/meloxicam

Ceva Santé Animale

10 av. de La Ballastière, 33500 Libourne, France

EU/2/17/210

Solution for injection

QJ01BA99

17.5.2017

17.5.2017

RESPIPORC FLUpan H1N1

Porcine influenza vaccine (inactivated)

IDT Biologika GmbH

Am Pharmapark, D-06861 Dessau-Rosslau, Deutschland

EU/2/17/209

Suspension for injection

QI09AA03

19.5.2017

24.5.2017

Ingelvac PCV FLEX

Porcine circovirus vaccine (inactivated)

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/17/208

Suspension for injection

QI09AA07

30.5.2017

| — | Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted |
| --- | --- |

—

Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 5.5.2017 | Activyl | Intervet International B.V.
  Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland | EU/2/10/118 | 9.5.2017 |
| 5.5.2017 | Kexxtone | Eli Lilly and Company Limited
  Elanco Animal Health, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL, United Kingdom | EU/2/12/145 | 9.5.2017 |
| 5.5.2017 | Versican Plus Pi/L4R | Zoetis Belgium S.A.
  Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique | EU/2/14/173 | 9.5.2017 |
| 15.5.2017 | NEXGARD SPECTRA | Merial
  29 avenue Tony Garnier, F-69007 Lyon, France | EU/2/14/177 | 17.5.2017 |
| 15.5.2017 | Novem | Boehringer Ingelheim Vetmedica GmbH
  D-55216 Ingelheim am Rhein, Deutschland | EU/2/04/042 | 17.5.2017 |
| 15.5.2017 | Poulvac E. coli | Zoetis Belgium S.A.
  Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique | EU/2/12/140 | 17.5.2017 |
| 15.5.2017 | Zactran | Merial
  29 avenue Tony Garnier, F-69007 Lyon, France | EU/2/08/082 | 17.5.2017 |
| 17.5.2017 | Suprelorin | VIRBAC S.A.
  1ère Avenue — 2065 m — L.I.D., F-06516 Carros Cedex, France | EU/2/07/072 | 19.5.2017 |
| 17.5.2017 | Suvaxyn Circo + MH RTU | Zoetis Belgium S.A.
  Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique | EU/2/15/190 | 22.5.2017 |
| 24.5.2017 | Activyl Tick Plus | Intervet International B.V.
  Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland | EU/2/11/137 | 30.5.2017 |
| 24.5.2017 | Profender | Bayer Animal Health GmbH
  D-51368 Leverkusen, Deutschland | EU/2/05/054 | 30.5.2017 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

5.5.2017

Activyl

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/10/118

9.5.2017

5.5.2017

Kexxtone

Eli Lilly and Company Limited

Elanco Animal Health, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL, United Kingdom

EU/2/12/145

9.5.2017

5.5.2017

Versican Plus Pi/L4R

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/173

9.5.2017

15.5.2017

NEXGARD SPECTRA

Merial

29 avenue Tony Garnier, F-69007 Lyon, France

EU/2/14/177

17.5.2017

15.5.2017

Novem

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/04/042

17.5.2017

15.5.2017

Poulvac E. coli

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/12/140

17.5.2017

15.5.2017

Zactran

Merial

29 avenue Tony Garnier, F-69007 Lyon, France

EU/2/08/082

17.5.2017

17.5.2017

Suprelorin

VIRBAC S.A.

1ère Avenue — 2065 m — L.I.D., F-06516 Carros Cedex, France

EU/2/07/072

19.5.2017

17.5.2017

Suvaxyn Circo + MH RTU

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/15/190

22.5.2017

24.5.2017

Activyl Tick Plus

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/11/137

30.5.2017

24.5.2017

Profender

Bayer Animal Health GmbH

D-51368 Leverkusen, Deutschland

EU/2/05/054

30.5.2017

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| European Medicines Agency |
| --- |
| 30 Churchill Place |
| Canary Wharf |
| London E14 5EU |
| United Kingdom |

European Medicines Agency

30 Churchill Place

Canary Wharf

London E14 5EU

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 30.6.2017 | EN | Official Journal of the European Union | C 208/10 |
| --- | --- | --- | --- |

30.6.2017

EN

Official Journal of the European Union

C 208/10

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2017 to 31 May 2017

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))

(2017/C 208/02)

| — | Issuing, maintenance or modification of a national marketing authorization |
| --- | --- |

—

Issuing, maintenance or modification of a national marketing authorization

| Date of the decision | Name(s) of the medicinal product | INN (International Non-Proprietary Name) | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- | --- |
| 5.5.2017 | Saroten and associated names | amitriptyline | See Annex | See Annex | 10.5.2017 |

Date of the decision

Name(s) of the medicinal product

INN (International Non-Proprietary Name)

Holder(s) of the marketing authorization

Member State concerned

Date of notification

5.5.2017

Saroten and associated names

amitriptyline

See Annex

See Annex

10.5.2017

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX

List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, Marketing Authorisation Holders in the Member States

| Member State EU/EEA | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical Form | Route of administration | Content (concentration) |
| --- | --- | --- | --- | --- | --- | --- |
| Austria | Lundbeck Austria GmbH
  Dresdner Strasse 82
  1200 Vienna
  Austria | Saroten | 10 mg | Film-coated tablet | Oral use | |
| Austria | Lundbeck Austria GmbH
  Dresdner Strasse 82
  1200 Vienna
  Austria | Saroten | 25 mg | Film-coated tablet | Oral use | |
| Austria | Lundbeck Austria GmbH
  Dresdner Strasse 82
  1200 Vienna
  Austria | Saroten Retard | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Austria | Lundbeck Austria GmbH
  Dresdner Strasse 82
  1200 Vienna
  Austria | Saroten Retard | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Belgium | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex | 10 mg | Film-coated tablet | Oral use | |
| Belgium | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex | 25 mg | Film-coated tablet | Oral use | |
| Belgium | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex Diffucaps | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Belgium | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex Diffucaps | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Cyprus | C. G. Papaloisou Ltd
  Office address:
  35 Kilkis Avenue
  2234 Latsia
  Cyprus
  Mail address:
  P.O. Box 1711
  2261 Latsia
  Cyprus | Saroten Retard | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Cyprus | C. G. Papaloisou Ltd
  Office address:
  35 Kilkis Avenue
  2234 Latsia
  Cyprus
  Mail address:
  P.O. Box 1711
  2261 Latsia
  Cyprus | Saroten Retard | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Denmark | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten | 10 mg | Film-coated tablet | Oral use | |
| Denmark | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten | 25 mg | Film-coated tablet | Oral use | |
| Denmark | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten Retard | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Denmark | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten Retard | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Estonia | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten Retard | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Germany | Bayer Vital GmbH
  Medizin/Zulassung
  51368 Leverkusen
  Germany | Saroten Tabs | 50 mg | Film-coated tablet | Oral use | |
| Germany | Bayer Vital GmbH
  Medizin/Zulassung
  51368 Leverkusen
  Germany | Saroten retard Tabs | 75 mg | Modified-release tablet | Oral use | |
| Germany | Bayer Vital GmbH
  Medizin/Zulassung
  51368 Leverkusen
  Germany | Saroten 2 ml | 50 mg/2 ml | Solution for injection | Intramuscular use
  intravenous use | 25 mg/ml |
| Greece | PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568 | SAROTEN | 25 mg | Modified-release capsule, hard | Oral use | |
| Greece | PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568 | SAROTEN | 75 mg | Modified-release capsule, hard | Oral use | |
| Greece | PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568 | SAROTEN | 25 mg | Coated tablet | Oral use | |
| Greece | PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568 | SAROTEN | 10 mg | Coated Tablet | Oral use | |
| Luxembourg | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex | 10 mg | Film-coated tablet | Oral use | |
| Luxembourg | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex | 25 mg | Film-coated tablet | Oral use | |
| Luxembourg | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex Diffucaps | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Luxembourg | Lundbeck S.A.
  Avenue Molière 225
  1050 Brussels
  Belgium | Redomex Diffucaps | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Netherlands | Lundbeck B.V.
  Gebouw Jupiter Herikerbergweg 100
  Postbus 12021
  1100 AA Amsterdam
  The Netherlands | Sarotex Retard 25 | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Netherlands | Lundbeck B.V.
  Gebouw Jupiter Herikerbergweg 100
  Postbus 12021
  1100 AA Amsterdam
  The Netherlands | Sarotex Retard 50 | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Norway | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Sarotex | 10 mg | Film-coated tablet | Oral use | |
| Norway | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Sarotex | 25 mg | Film-coated tablet | Oral use | |
| Norway | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Sarotex Retard | 25 mg | Prolonged-release capsule, hard | Oral use | |
| Norway | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Sarotex Retard | 50 mg | Prolonged-release capsule, hard | Oral use | |
| Sweden | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten | 10 mg | Film-coated tablet | Oral use | |
| Sweden | H. Lundbeck A/S
  Ottiliavej 9
  2500 Valby
  Denmark | Saroten | 25 mg | Film-coated tablet | Oral use | |

Member State EU/EEA

Marketing Authorisation Holder

Invented name

Strength

Pharmaceutical Form

Route of administration

Content (concentration)

Austria

Lundbeck Austria GmbH

Dresdner Strasse 82

1200 Vienna

Austria

Saroten

10 mg

Film-coated tablet

Oral use

Austria

Lundbeck Austria GmbH

Dresdner Strasse 82

1200 Vienna

Austria

Saroten

25 mg

Film-coated tablet

Oral use

Austria

Lundbeck Austria GmbH

Dresdner Strasse 82

1200 Vienna

Austria

Saroten Retard

25 mg

Prolonged-release capsule, hard

Oral use

Austria

Lundbeck Austria GmbH

Dresdner Strasse 82

1200 Vienna

Austria

Saroten Retard

50 mg

Prolonged-release capsule, hard

Oral use

Belgium

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex

10 mg

Film-coated tablet

Oral use

Belgium

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex

25 mg

Film-coated tablet

Oral use

Belgium

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex Diffucaps

25 mg

Prolonged-release capsule, hard

Oral use

Belgium

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex Diffucaps

50 mg

Prolonged-release capsule, hard

Oral use

Cyprus

C. G. Papaloisou Ltd

Office address:

35 Kilkis Avenue

2234 Latsia

Cyprus

Mail address:

P.O. Box 1711

2261 Latsia

Cyprus

Saroten Retard

25 mg

Prolonged-release capsule, hard

Oral use

Cyprus

C. G. Papaloisou Ltd

Office address:

35 Kilkis Avenue

2234 Latsia

Cyprus

Mail address:

P.O. Box 1711

2261 Latsia

Cyprus

Saroten Retard

50 mg

Prolonged-release capsule, hard

Oral use

Denmark

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten

10 mg

Film-coated tablet

Oral use

Denmark

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten

25 mg

Film-coated tablet

Oral use

Denmark

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten Retard

25 mg

Prolonged-release capsule, hard

Oral use

Denmark

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten Retard

50 mg

Prolonged-release capsule, hard

Oral use

Estonia

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten Retard

50 mg

Prolonged-release capsule, hard

Oral use

Germany

Bayer Vital GmbH

Medizin/Zulassung

51368 Leverkusen

Germany

Saroten Tabs

50 mg

Film-coated tablet

Oral use

Germany

Bayer Vital GmbH

Medizin/Zulassung

51368 Leverkusen

Germany

Saroten retard Tabs

75 mg

Modified-release tablet

Oral use

Germany

Bayer Vital GmbH

Medizin/Zulassung

51368 Leverkusen

Germany

Saroten 2 ml

50 mg/2 ml

Solution for injection

Intramuscular use

intravenous use

25 mg/ml

Greece

PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568

SAROTEN

25 mg

Modified-release capsule, hard

Oral use

Greece

PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568

SAROTEN

75 mg

Modified-release capsule, hard

Oral use

Greece

PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568

SAROTEN

25 mg

Coated tablet

Oral use

Greece

PNG GEROLYMATOS MEDICAL AE, ASKLIPIOU 13, KRYONERI 14568

SAROTEN

10 mg

Coated Tablet

Oral use

Luxembourg

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex

10 mg

Film-coated tablet

Oral use

Luxembourg

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex

25 mg

Film-coated tablet

Oral use

Luxembourg

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex Diffucaps

25 mg

Prolonged-release capsule, hard

Oral use

Luxembourg

Lundbeck S.A.

Avenue Molière 225

1050 Brussels

Belgium

Redomex Diffucaps

50 mg

Prolonged-release capsule, hard

Oral use

Netherlands

Lundbeck B.V.

Gebouw Jupiter Herikerbergweg 100

Postbus 12021

1100 AA Amsterdam

The Netherlands

Sarotex Retard 25

25 mg

Prolonged-release capsule, hard

Oral use

Netherlands

Lundbeck B.V.

Gebouw Jupiter Herikerbergweg 100

Postbus 12021

1100 AA Amsterdam

The Netherlands

Sarotex Retard 50

50 mg

Prolonged-release capsule, hard

Oral use

Norway

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Sarotex

10 mg

Film-coated tablet

Oral use

Norway

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Sarotex

25 mg

Film-coated tablet

Oral use

Norway

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Sarotex Retard

25 mg

Prolonged-release capsule, hard

Oral use

Norway

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Sarotex Retard

50 mg

Prolonged-release capsule, hard

Oral use

Sweden

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten

10 mg

Film-coated tablet

Oral use

Sweden

H. Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

Saroten

25 mg

Film-coated tablet

Oral use

---